NanoViricides
NNVC
34 hedge funds and large institutions have $4.68M invested in NanoViricides in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 4 closing their positions.
151% more capital invested
Capital invested by funds: $1.86M → $4.68M (+$2.82M)
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
17% more funds holding
Funds holding: 29 → 34 (+5)
3.2% more ownership
Funds ownership: 6.09% → 9.29% (+3.2%)
39% less call options, than puts
Call options by funds: $239K | Put options by funds: $395K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$835K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$276K |
| 3 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$181K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$137K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$124K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$217K |
| 2 |
Millennium Management
New York
|
-$62K |
| 3 |
Morgan Stanley
New York
|
-$21.5K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.71K |
| 5 |
HIS
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
-$1.33K |
NNVC Hedge Fund Activity: Q1 2021 in Review
34 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2021, worth a combined $4.68M — up 151% from $1.86M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NNVC positions and 4 closed out — a net gain of 5 holders — while 11 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $835K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $217K sold.
- 34 institutional investors held NanoViricides (NNVC) as of Q1 2021, up from 29 in Q4 2020.
- Funds reported $4.68M of NanoViricides stock for Q1 2021, up 151% quarter-over-quarter.
- 9 funds opened new NanoViricides positions in Q1 2021 and 4 closed out, a net change of +5 holders.
- The largest NanoViricides buyer in Q1 2021 was Vanguard Group, an estimated $835K added.
- The largest NanoViricides seller in Q1 2021 was Renaissance Technologies, an estimated $217K sold.
Based on aggregated 13F filings for Q1 2021.